Focal segmental glomerulosclerosis (FSGS) is a disease typified by formation of scar tissue in some of the glomeruli of the kidney. The disease may develop from a systemic disorder, or as an idiopathic kidney disease. The major symptom associated with FSGS is proteinuria. However, in children, it usually presents as nephrotic syndrome, characterized by hypoalbuminemia, hyperlipidemia, and hypertension. In fact, about 10-15% cases of proteinuria are attributed to FSGS. This is a serious disease, with most patients tending to progress towards long term, chronic renal failure, and end stage renal disease over a period of 5 to20 years.
Since proteinuria is associated with many other diseases involving the kidney, it cannot be used as the sole diagnostic factor for FSGS. Histopathological studies on kidney biopsies are most useful in this case. The biopsy may show scarring of some parts, as well as positive staining for antibody IgM. Management of the disease involves administration of corticosteroids and immunosuppressants. ACE inhibitors and diuretics can be used to control the associated hypertension. However, the benefit of treatment varies among individuals. In most cases, patients with FSGS proceed towards chronic renal failure.